| Amgen (AMGN) |
United States |
$107.422B |
12.15 |
| Gilead Sciences (GILD) |
United States |
$86.782B |
10.54 |
| Celgene (CELG) |
United States |
$64.715B |
10.96 |
| Biogen (BIIB) |
United States |
$45.297B |
8.60 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$45.172B |
54.60 |
| Illumina (ILMN) |
United States |
$44.437B |
51.50 |
| CSL (CSLLY) |
Australia |
$35.310B |
0.00 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$32.586B |
15.32 |
| Actelion (ALIOF) |
Switzerland |
$29.891B |
0.00 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$27.590B |
15.61 |
| Incyte (INCY) |
United States |
$17.453B |
70.77 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$15.040B |
0.00 |
| Exact Sciences (EXAS) |
United States |
$15.005B |
0.00 |
| SINO PHARMACEUT (SBMFF) |
China |
$14.407B |
0.00 |
| Sarepta Therapeutics (SRPT) |
United States |
$11.635B |
0.00 |
| Genmab (GNMSF) |
Denmark |
$11.067B |
56.26 |
| Array BioPharma (ARRY) |
United States |
$10.358B |
0.00 |
| Seattle Genetics (SGEN) |
United States |
$10.323B |
0.00 |
| Bio-Rad Laboratories (BIO.B) |
United States |
$9.283B |
49.21 |
| QIAGEN (QGEN) |
Netherlands |
$9.032B |
29.67 |
| Galapagos (GLPG) |
Belgium |
$8.749B |
0.00 |
| Guardant Health (GH) |
United States |
$8.099B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$7.974B |
54.41 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$7.755B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$7.483B |
0.00 |
| Amarin (AMRN) |
Ireland |
$7.232B |
0.00 |
| Exelixis (EXEL) |
United States |
$6.464B |
16.48 |
| BeiGene (BGNE) |
Cayman Islands |
$5.733B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$4.717B |
0.00 |
| Moderna (MRNA) |
United States |
$4.711B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$4.686B |
0.00 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$4.616B |
0.00 |
| Horizon Pharma Public (HZNP) |
Ireland |
$4.348B |
11.20 |
| Repligen (RGEN) |
United States |
$4.059B |
101.12 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.852B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$3.805B |
0.00 |
| Spark Therapeutics (ONCE) |
United States |
$3.765B |
0.00 |
| China Biologic Products (CBPO) |
China |
$3.689B |
23.43 |
| Alkermes (ALKS) |
Ireland |
$3.662B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$3.369B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$3.287B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.077B |
6.25 |
| Amicus Therapeutics (FOLD) |
United States |
$2.888B |
0.00 |
| Immunomedics (IMMU) |
United States |
$2.724B |
0.00 |
| Medicines (MDCO) |
United States |
$2.713B |
0.00 |
| UniQure (QURE) |
Netherlands |
$2.633B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$2.607B |
0.00 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.582B |
0.00 |
| Halozyme Therapeutics (HALO) |
United States |
$2.461B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$2.328B |
0.00 |
| MyoKardia (MYOK) |
United States |
$2.314B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.291B |
18.98 |
| Emergent Biosolutions (EBS) |
United States |
$2.238B |
19.44 |
| Akcea Therapeutics (AKCA) |
United States |
$2.178B |
0.00 |
| Acceleron Pharma (XLRN) |
United States |
$2.159B |
0.00 |
| NeoGenomics (NEO) |
United States |
$2.133B |
139.63 |
| Genomic Health (GHDX) |
United States |
$2.121B |
45.04 |
| Zai Lab (ZLAB) |
China |
$2.116B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$2.064B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$1.970B |
0.00 |
| Myriad Genetics (MYGN) |
United States |
$1.912B |
19.02 |
| REGENXBIO (RGNX) |
United States |
$1.759B |
0.00 |
| Insmed (INSM) |
United States |
$1.725B |
0.00 |
| Cambrex (CBM) |
United States |
$1.523B |
19.25 |
| AnaptysBio (ANAB) |
United States |
$1.504B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$1.443B |
0.00 |
| Innoviva (INVA) |
United States |
$1.428B |
3.95 |
| RA PHARMCTL INC (RARX) |
United States |
$1.404B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.384B |
0.00 |
| Athenex (ATNX) |
United States |
$1.341B |
0.00 |
| Alector (ALEC) |
United States |
$1.309B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.308B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$1.245B |
0.00 |
| Epizyme (EPZM) |
United States |
$1.240B |
0.00 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$1.188B |
0.00 |
| Momenta Pharmaceuticals (MNTA) |
United States |
$1.050B |
0.00 |
| Codexis (CDXS) |
United States |
$1.022B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$1.010B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.986B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.973B |
17.26 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$0.970B |
0.00 |
| Alder BioPharmaceuticals (ALDR) |
United States |
$0.950B |
0.00 |
| Principia Biopharma (PRNB) |
United States |
$0.945B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$0.942B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$0.936B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.925B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.924B |
0.00 |
| Retrophin (RTRX) |
United States |
$0.879B |
0.00 |
| Vericel (VCEL) |
United States |
$0.861B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$0.856B |
0.00 |
| Arvinas (ARVN) |
United States |
$0.805B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$0.767B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$0.719B |
33.92 |
| Precision BioSciences (DTIL) |
United States |
$0.693B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.687B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$0.683B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$0.676B |
7.90 |
| Cellectis S.A (CLLS) |
France |
$0.654B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.646B |
0.00 |
| Cytokineticsorporated (CYTK) |
United States |
$0.639B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.631B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$0.630B |
0.00 |
| Heska (HSKA) |
United States |
$0.629B |
64.40 |
| DBV Technologies S.A (DBVT) |
France |
$0.621B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$0.575B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.573B |
19.58 |
| MiMedx (MDXG) |
United States |
$0.561B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$0.552B |
0.00 |
| Stemline Therapeutics (STML) |
United States |
$0.551B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.534B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.521B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.503B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$0.459B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.446B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.442B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.433B |
0.00 |
| Gritstone Oncology (GRTS) |
United States |
$0.395B |
0.00 |
| Prothena (PRTA) |
Ireland |
$0.386B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.385B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.376B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.373B |
8.91 |
| AC Immune SA (ACIU) |
Switzerland |
$0.372B |
23.96 |
| Arcus Biosciences (RCUS) |
United States |
$0.371B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.371B |
0.00 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.366B |
0.00 |
| Bellus Health (BLUSF) |
Canada |
$0.359B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.358B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$0.352B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.350B |
0.00 |
| Albireo Pharma (ALBO) |
United States |
$0.347B |
0.00 |
| Achillion Pharmaceuticals (ACHN) |
United States |
$0.343B |
0.00 |
| Prometic Life Sciences (PFSCD) |
Canada |
$0.341B |
0.00 |
| Agenus (AGEN) |
United States |
$0.341B |
0.00 |
| Senesco Technologies (ELOX) |
United States |
$0.338B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.337B |
0.00 |
| Theratechnologies (THERF) |
Canada |
$0.330B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.321B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.319B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.316B |
5.56 |
| AMAG Pharmaceuticals (AMAG) |
United States |
$0.312B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$0.308B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$0.308B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.305B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$0.290B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.271B |
0.00 |
| Cellular Biomedicine (CBMG) |
United States |
$0.266B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.263B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.263B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.262B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.250B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.243B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.236B |
9.16 |
| Athersys (ATHX) |
United States |
$0.234B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.233B |
0.00 |
| Cel-Sci (CVM) |
United States |
$0.231B |
0.00 |
| Geron (GERN) |
United States |
$0.229B |
0.00 |
| Palatin Technologies (PTN) |
United States |
$0.226B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.210B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.210B |
0.00 |
| Cerecor (CERC) |
United States |
$0.208B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.207B |
0.00 |
| MannKind (MNKD) |
United States |
$0.205B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.204B |
0.00 |
| Five Prime Therapeutics (FPRX) |
United States |
$0.202B |
0.00 |
| Pfenex (PFNX) |
United States |
$0.197B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.197B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.196B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
|
$0.194B |
0.00 |
| Mersana Therapeutics (MRSN) |
United States |
$0.190B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.188B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.187B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.185B |
0.00 |
| Arsanis (XFOR) |
United States |
$0.184B |
0.00 |
| BioTime (BTX) |
United States |
$0.180B |
12.00 |
| Compugen (CGEN) |
Israel |
$0.177B |
0.00 |
| Newron Pharmaceuticals SpA (NWPHF) |
|
$0.165B |
0.00 |
| Nicox SA (NICXF) |
France |
$0.163B |
0.00 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.160B |
0.00 |
| XOMA (XOMA) |
United States |
$0.159B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.155B |
8.94 |
| Liquidia Technologies (LQDA) |
United States |
$0.146B |
0.00 |
| Cue Biopharma (CUE) |
United States |
$0.144B |
0.00 |
| OvaScience (MLND) |
United States |
$0.144B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.140B |
0.00 |
| Adocia (ADOCY) |
France |
$0.140B |
0.00 |
| TOCAGEN INC (TOCA) |
United States |
$0.138B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.138B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$0.133B |
0.00 |
| Arbutus Biopharma (ABUS) |
Canada |
$0.133B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.128B |
0.00 |
| Aduro Biotech (ADRO) |
United States |
$0.122B |
0.00 |
| Menlo Therapeutics (MNLO) |
United States |
$0.119B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.119B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.117B |
0.00 |
| Alcobra (ARCT) |
United States |
$0.117B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$0.115B |
0.00 |
| Novavax (NVAX) |
United States |
$0.111B |
0.00 |
| NantKwest (NK) |
United States |
$0.111B |
0.00 |
| Nymox Pharmaceutical (NYMX) |
Canada |
$0.110B |
0.00 |
| Verastem (VSTM) |
United States |
$0.108B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.103B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.100B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.099B |
0.00 |
| Trevena (TRVN) |
United States |
$0.098B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.098B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.095B |
0.00 |
| Catabasis Pharmaceuticals (CATB) |
United States |
$0.086B |
0.00 |
| AquaBounty Technologies (AQB) |
United States |
$0.085B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.084B |
0.00 |
| Aridis Pharmaceuticals (ARDS) |
United States |
$0.084B |
0.00 |
| Curis (CRIS) |
United States |
$0.082B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.080B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.078B |
0.00 |
| Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.078B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.077B |
0.00 |
| Merrimack Pharmaceuticals (MACK) |
United States |
$0.075B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.070B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.069B |
38.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.069B |
0.00 |
| Unum Therapeutics (UMRX) |
United States |
$0.069B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.067B |
0.00 |
| Signal Genetics (MGEN) |
United States |
$0.065B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.065B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.064B |
0.00 |
| Sunesis Pharmaceuticals (SNSS) |
United States |
$0.062B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.062B |
0.00 |
| Protalix BioTherapeutics (PLX) |
Israel |
$0.061B |
0.00 |
| Invo BioScience (IVOB) |
United States |
$0.059B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.059B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.058B |
0.00 |
| NewLink Genetics (NLNK) |
United States |
$0.054B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.052B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.051B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.051B |
0.00 |
| Proteostasis Therapeutics (PTI) |
United States |
$0.050B |
0.00 |
